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EXERCISE OR NEUROMUSCULAR ELECTRICAL 
STIMULATION: WHICH ONE IS MORE EFFECTIVE IN 
QUADRICEPS FAT MASS REDUCTION AND STRENGTH 
INCREASE IN OSTEOARTHRITIC KNEES? 
G Baltaci, V Bayrakci Tunay, E Yakut, N Vardar 
Physical Therapy and Rehabilitation, Hacettepe University, 
Ankara, Turkey 
Aims of Study: Patients with osteoarthritis (OA) have quadri- 
ceps weakness, pain in activity and quadriceps muscle inhibi- 
tion (QMI).The purpose of this study was to assess the effects 
of two different reatment programme on the quadriceps muscle 
fat mass and strength. 
Methods: Thirty-four females with bilateral knee OA (Altman 
Grade II) were divided into 2 random groups (GI to GII). The pa- 
tients in group I received pilates exercise (45 min) and group II 
received neuromuscular electrical stimulation (NMES) (30 min) 
5 times weekly for 4 weeks. The mean age and body mass in- 
dex (BMI) of the patients in GI were 504-6.21and 28.064-5.06 
and in GII were 53.264-8.9 and 28.524-5.13. Visual analogue 
scale (VAS) was used to measure knee pain intensity during ac- 
tivity. Symptoms were monitored by the "Western Ontario and 
McMaster Universities" (WOMAC) OA index. Fat thickness was 
measured with Skyndex System I (Caldwell, Justiss&Company, 
Inc,from quadriceps muscle belly. Quadriceps muscle strength 
was evaluated with Nicholas manuel muscle tester. All tests were 
done before and after treatment. 
Results: Statistically significant differences were found in all tests 
in GI before and after 4 weeks treatment evaluations (p<0.05), 
but in GII there was no statistically significant difference found 
in quadriceps strength (p>0.05). Quadriceps strength was in- 
creased %1 in GI (p<0.05) and % 0.5 in GII (p>0.05). Thigh fat 
thickness was decreased %1.12 in GI (p<0.05), % 0.46 in GII 
(P<0.05). 
Conclusions: Exercise programmes and physical therapy 
modalities that facilitate muscle activation like NMES are neces- 
sary to enhance the quadriceps trength and reduce fat mass in 
the patients with knee OA. But exercises are more effective in 
these improvements. 
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GLUCOSAMINE PLASMA AND SYNOVIAL FLUID 
CONCENTRATIONS BEFORE AND AFTER ORAL 
ADMINISTRATION OF CRYSTALLINE GLUCOSAMINE 
SULFATE IN KNEE OSTEOARTHRITIS PATIENTS 
S Persiani 1 , R Rotini 2, G Trisolino 2, LC Rovati 1 , M Locatelli 3, A 
Roda 3 
1Clinical Pharmacology Dept., Rottapharm, Monza, Mi, Italy; 
2 Codivilla Dept., Rizzofi Orthopaedic Institute, Bologna, Italy; 
3Dept. Pharmaceutical Sciences, University of Bologna, 
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Aim of Study: The pharmacokinetics of glucosamine in plasma 
has been recently described after oral administration to healthy 
volunteers of crystalline glucosamine sulfate, i.e. the only glu- 
cosamine formulation shown to be a symptom- and structure- 
modifying drug in osteoarthritis. The aim of the present study was 
to assess glucosamine levels in plasma and synovial fluid before 
and after administration of crystalline glucosamine sulfate in ther- 
apeutic doses to patients with knee osteoarthritis. 
Methods: Five patients (3 men, 2 women) with knee osteoarthri- 
tis received oral crystalline glucosamine sulfate soluble powder 
1500 mg once-a-day (Rottapharm, Monza, Italy) for 14 consecu- 
tive days. Blood and synovial fluid samples were collected before 
the first drug administration and 3 hours after the last administra- 
tion, when steady state plasma concentrations were at maximum 
in the previous healthy volunteer study. Glucosamine concentra- 
tions were determined by a Liquid Chromatography with Mass 
Spectrometry detection (LC-MS/MS) method, with a quantitation 
limit of 2 ng/ml. 
Results: The mean (SE) age, height, weight and BMI of the 
enrolled patients were 534-5 years, 1714-6 cm, 804-7 kg and 
26.84-1.3 kg/cm 2, respectively. Endogenous glucosamine was 
detected in baseline plasma and synovial fluid samples, with 
mean (SE) concentrations of 39.54-5.1 ng/ml (0.24-0.03 I~M) and 
15.14-6.8 ng/ml (0.084-0.04 I~M), respectively. Three hours after 
the last glucosamine sulfate administration, baseline-subtracted 
concentrations were 14194-711 ng/ml (7.94-3.9 I~M) in plasma 
and 12914-576 ng/ml (7.24-3.2 I~M) in the synovial fluid. 
Conclusions: As in healthy volunteers, endogenous glu- 
cosamine is present in plasma of knee osteoarthritis patients and 
reaches concentrations in the 10 I~M range after repeated oral 
doses of crystalline glucosamine sulfate. We describe here for 
the first time that endogenous glucosamine is detectable also 
in the synovial fluid of knee osteoarthritis patients and that, af- 
ter repeated dosing, the plasma and synovial fluid concentra- 
tions achieved are similar. Glucosamine concentrations in the 
10 I~M range are effective in selected human chondrocyte mod- 
els. Nevertheless, further studies are needed to investigate glu- 
cosamine mechanism of action at these concentrations, as well 
as the pathophysiological relevance of different endogenous lev- 
els in osteoarthritis patients and the correlation between the lev- 
els achieved after exogenous administration and the treatment 
response. 
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EXTRACORPOREALSHOCK-WAVE THERAPY IMPROVE 
MOTOR DYSFUNCTION AND PAIN ORIGINATED FROM 
KNEE OSTEOARTHRITIS 
N Ochiai 1 , S Ohtori 1 , T Sasho ~ , R Murata ~ , H Moriya ~ , Y 
Wada 2, T Saisu 3 
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Introduction: There have been several reports on the use of ex- 
tracorporeal shock waves (ESW) in the treatment of pseudarthro- 
sis, calcifying tendinitis, and tennis elbow. However, efficacy of 
ESW treatment for knee osteoarthritis (OA) has not been clari- 
fied. 
Purpose; To investigate the effect of ESW application for knee 
OA, we analyzed walking duration using treadmill and changes 
of calcitonin gene-related peptide (CGRP), which is a marker of 
inflammatory pain, in dorsal root ganglion (DRG) neurons in OA 
rats immunohistochemistry. 
Material and method: OA model: We transected anterior cruci- 
ate ligament, medial meniscus and medial collateral igament o 
make OA model, and evaluated 18 knee OA rats 6 months after 
surgery. 
Behavioral test: Six knee OA rats were used for behavioral anal- 
ysis. We measured walking duration before application of shock 
wave, on 2 days, 4 days, 7 days, 14 days, 21 days and 28 days af- 
ter ESW application, and these distances were statistically com- 
pared by non paired t-test. 
Immunohistochemistry: We used 3 groups. 1) Control group (6 
knees) 2) OA group (6 knees) 3) OA + ESW group (6 knees). 
Fuorogold (FG) (neurotracer) were injected into the medial knee 
joint to detect DRG neurons innervating knee in 3 groups. In the 
ESW group, shock wave (1000 shots, 4Hz, 0.08mJ/mm2: Dornier 
Epos) was applied into the medial knee joint 10 days after in- 
